PlainRecalls
FDA Drug Low Class III Terminated

Temozolomide Capsules, 5 mg, packaged in a) 5-count bottle (NDC 43975-252-05) b) 14-count bottle (NDC 43975-252-14), Rx only, Mfd. by: Stason Pharmaceuticals, Inc., Irvine, CA 92618, Dist. By: Amerigen Pharmaceuticals, Lyndhurst, NJ 07071

Reported: February 27, 2019 Initiated: February 19, 2019 #D-0516-2019

Product Description

Temozolomide Capsules, 5 mg, packaged in a) 5-count bottle (NDC 43975-252-05) b) 14-count bottle (NDC 43975-252-14), Rx only, Mfd. by: Stason Pharmaceuticals, Inc., Irvine, CA 92618, Dist. By: Amerigen Pharmaceuticals, Lyndhurst, NJ 07071

Reason for Recall

Failed dissolution specifications

Details

Units Affected
a) 2,413 bottles b) 3,355 bottles
Distribution
Product was distributed to 4 wholesalers/distributors and 1 retail account who may have further distribute the product throughout the United States.
Location
Lyndhurst, NJ

Frequently Asked Questions

What product was recalled?
Temozolomide Capsules, 5 mg, packaged in a) 5-count bottle (NDC 43975-252-05) b) 14-count bottle (NDC 43975-252-14), Rx only, Mfd. by: Stason Pharmaceuticals, Inc., Irvine, CA 92618, Dist. By: Amerigen Pharmaceuticals, Lyndhurst, NJ 07071. Recalled by Amerigen Pharmaceuticals Inc.. Units affected: a) 2,413 bottles b) 3,355 bottles.
Why was this product recalled?
Failed dissolution specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on February 27, 2019. Severity: Low. Recall number: D-0516-2019.